COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect COMPASS Pathways to post earnings of ...

COMPASS Pathways (NASDAQ:CMPS – Free Report) had its price target reduced by HC Wainwright from $60.00 to $45.00 in a report ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, a ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways (CMPS – Research Report) today and set a price target of ...

H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $45 from $60 and keeps a Buy rating on the shares. The firm says ...

Boris Johnson, who was in No 10 when the war started, claimed Trump’s statements are “not intended to be historically ...

India’s Digital Personal Data Protection Act, 2023 (“DPDPA”) marks a significant step in enhancing digital privacy by introducing Consent Managers, which will a ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the ...

For many patients, getting ready to have surgery means getting their blood drawn, their heart rhythm checked, or having other ...

H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...